S&P Futures
4,168.00+10.25(+0.25%)Dow Futures
34,361.00+105.00(+0.31%)Nasdaq Futures
13,347.50+44.00(+0.33%)
Immunovant, Inc. (IMVT)
15.12 -0.38 (-2.45%)
After hours: 4:37PM EDT
Chart Events
Performance Outlook
| Previous Close | 15.50 |
| Open | 15.37 |
| Bid | 15.15 x 900 |
| Ask | 15.84 x 800 |
| Day's Range | 15.18 - 15.94 |
| 52 Week Range | 11.80 - 53.75 |
| Volume | 217,015 |
| Avg. Volume | 1,649,630 |
| Market Cap | 1.519B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Feb 16, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 39.10 |
- Barrons.com
Will Biotech Stocks’ Slide Become a Rout? June Holds the Key.
The leading exchange-traded funds that track the industry are down precipitously this spring as a number of companies have reported bad news.
- ACCESSWIRE
Last Chance to Actively Participate: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. (IMVT) Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021
NEW YORK, NY / ACCESSWIRE / April 20, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Immunovant, Inc. ("Immunovant" or "the Company") (NASDAQ:IMVT) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Immunovant securities between October 2, 2019 and February 1, 2021, both dates inclusive (the "Class Period").
- ACCESSWIRE
INVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 20, 2021 /The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Immunovant, Inc. ("Immunovant" or "the Company") (NASDAQ:IMVT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.
